"Wheaton's portfolio of high-quality, long-life assets delivered another outstanding year in 2025, surpassing our production guidance and achieving record revenue, earnings, and operating cash flow," ...
All amounts expressed in U.S. dollars unless otherwise indicated. Unaudited tabular amounts are in millions of U.S. dollars and thousands of shares, except per ounce amounts, unless otherwise noted.
(NYSE/TSX: MUX) today announced its fourth quarter (Q4) and full year results for the period ended December 31, 2025, along ...
Fourth Quarter Revenues Increase 3.1% Year over Year - - Full Year Revenues of $54.9 Million, Net Income of $2.9 Million and ...
TORONTO, March 5, 2026 /PRNewswire/ - Spin Master Corp. ("Spin Master" or the "Company") (TSX: TOY) a leading global children's entertainment ...
Fourth Quarter Revenue Increased 20% to a Record $23.4 Million Full Year 2025 Revenue Increased 20% to $90.3 Million, Generating GAAP EPS of $0.91 BOCA RATON, Fla., March 04, 2026 (GLOBE NEWSWIRE) -- ...
Zevra Therapeutics, Inc. is rated a Buy, delivered robust FY25 results, with 350% revenue growth to $106.5M. Learn more about ZVRA stock here.
ADMA Biologics, Inc. (Nasdaq: ADMA) ("ADMA" or the "Company"), a U.S. based, end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics, ...
I know it can be irritating to be asked to subscribe to get additional information – especially when you've relied on Moneyweb's free data for years. But the cost of sourcing th ...
College is about learning, not earning, but students need extra cash. Discover side hustles for college students that fit ...